These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33384601)

  • 21. Prognostic value and immunological role of cathepsin S gene in pan‑cancer.
    Liang S; Dang B; Chen S; Mi H
    Oncol Lett; 2024 Jan; 27(1):41. PubMed ID: 38108072
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Ke P; Bao X; Liu C; Zhou B; Huo M; Chen Y; Wang X; Wu D; Ma X; Liu D; Chen S
    Transl Cancer Res; 2022 Oct; 11(10):3491-3505. PubMed ID: 36388050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
    Zhao C; Yu M; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer.
    Liang T; Han L; Guo L
    Comput Struct Biotechnol J; 2020; 18():1238-1248. PubMed ID: 32542110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-Cancer Analysis Based on
    Zhang Y; Wang S; Han S; Feng Y
    Front Oncol; 2022; 12():844794. PubMed ID: 35359375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pan-cancer analysis of the role of
    Ding G; Ma T; Zhang K; Chen G; Shen J; Zhang S; Li K; Zhao C; Wang F; Sun J; Wang J
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-16. PubMed ID: 36971139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer.
    Ping W; Hong S; Xun Y; Li C
    Biomed Res Int; 2022; 2022():4436646. PubMed ID: 35937402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
    Ma J; Jin Y; Gong B; Li L; Zhao Q
    Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the PD-1 Ligands Among Gastrointestinal Cancer Patients: Focus on Cancer Immunity.
    Dai L; Huang Z; Li W
    Front Oncol; 2021; 11():637015. PubMed ID: 33833994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein regulator of cytokinesis 1: a potential oncogenic driver.
    Li S; Motiño O; Lambertucci F; Martins I; Sun L; Kroemer G
    Mol Cancer; 2023 Aug; 22(1):128. PubMed ID: 37563591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
    Fei L; Lu Z; Xu Y; Hou G
    Front Genet; 2022; 13():920897. PubMed ID: 36035140
    [No Abstract]   [Full Text] [Related]  

  • 32. Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers.
    Fu J; Li D; Zhang L; Maghsoudloo M; Cheng J; Fu J
    Cancer Cell Int; 2024 Aug; 24(1):279. PubMed ID: 39118110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors.
    Yuan Z; Wang L; Chen C
    Front Oncol; 2022; 12():963719. PubMed ID: 36158677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity.
    Chen F; Fan Y; Liu X; Zhang J; Shang Y; Zhang B; Liu B; Hou J; Cao P; Tan K
    Front Mol Biosci; 2021; 8():789703. PubMed ID: 35087869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets.
    Zhang Y; Gao C; Cao F; Wu Y; Chen S; Han X; Mo J; Qiu Z; Fan W; Zhou P; Shen L
    Front Oncol; 2021; 11():755341. PubMed ID: 34804946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Peng T; Liu B; Lin S; Cao C; Wu P; Zhi W; Wei Y; Chu T; Gui L; Ding W
    Heliyon; 2022 Dec; 8(12):e12191. PubMed ID: 36568653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers.
    Peng L; Chen Z; Chen Y; Wang X; Tang N
    Cancer Med; 2019 Dec; 8(17):7161-7173. PubMed ID: 31568700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of CD68 in tumor immunity and prognosis prediction in pan-cancer.
    Zhang J; Li S; Liu F; Yang K
    Sci Rep; 2022 May; 12(1):7844. PubMed ID: 35550532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.
    Fu J; Song B; Du J; Liu S; He J; Xiao T; Zhou B; Li D; Liu X; He T; Cheng J; Fu J
    Mol Biol Rep; 2023 Mar; 50(3):2269-2281. PubMed ID: 36574092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis.
    Yi Q; Peng J; Xu Z; Liang Q; Cai Y; Peng B; He Q; Yan Y
    Front Bioeng Biotechnol; 2022; 10():806851. PubMed ID: 35910024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.